SCHEMBL4339118

SCHEMBL4339118

Cc1ccc(COC(=O)Nc2ccc(F)c(CC(OC(C)C)C(=O)O)c2)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.41
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
LMNA P02545 3/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
TSHR P16473 2/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
ROCK2 O75116 1/20 0.36
TACR1 P25103 1/20 0.36
MGLL Q99685 1/20 0.36
FFAR1 O14842 1/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4341546 0.90 KMT2A (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4337986 0.88 SCD (0.42) SCDMEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL13810699 0.88 ALDH1A1 (0.43) SCDALDH1A1MEN1KMT2ALMNA
SCHEMBL4337063 0.88 PTGDR2 (0.44) SCDALDH1A1MEN1KMT2ALMNA
SCHEMBL4341512 0.86 TP53 (0.40) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL4329694 0.86 MGLL (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4341216 0.84 PPARG (0.45) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4333133 0.83 MGLL (0.46) LMNASMN1; SMN2MAPTTACR1MGLL
SCHEMBL4332360 0.83 PPARG (0.42) L3MBTL1MAPTNPC1TP53RAB9A
SCHEMBL4341732 0.82 NPC1 (0.42) ALDH1A1SMN1; SMN2TSHRMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 SCD 1041/4885ALDH1A1 844/4885MEN1 4091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.